673. Hung KL, et al. (2022) Nat Genet, 54: 1746. 674. Wu S, et al. (2019) Nature, 575: 699. 675. Zhu Y, et al. (2021) Cancer Cell, 39: 694. 676. Gu X, et al. (2020) J Exp Clin Cancer Res, 39: 215. 677. Zeng X, et al. (2020) Signal Transduct Target Ther, 5: 277. 678. ClinicalTrials.gov. Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy, in Subjects With Tumors With Oncogene Amplifications (POTENTIATE). Accessed: July 31, 2023. Available from: https://www. clinicaltrials.gov/study/NCT05827614. 679. Dubash SR, et al. (2016) J Nucl Med, 57: 1207. 680. Bauer D, et al. (2023) Nat Protoc, 18: 1659. 681. Stanczak MA, et al. (2022) Sci Transl Med, 14: eabj1270. 682. ClinicalTrials.gov. Cancer Preventive Vaccine Nous209 for Lynch Syndrome Patients - Full Text View - ClinicalTrials.gov. Accessed: July 5, 2023. Available from: https://clinicaltrials.gov/ct2/show/NCT05078866. 683. Shreve JT, et al. (2022) Am Soc Clin Oncol Educ Book, 42: 1. 684. Torrente M, et al. (2022) Cancers (Basel), 14. 685. Chen RJ, et al. (2022) Cancer Cell, 40: 865. 686. Han M, et al. (2023) Nature, 615: 712. 687. (2023) Nat Med, 29: 793. 688. Wang K, et al. (2018) PLoS One, 13: e0205548. 689. Grewal JK, et al. (2019) JAMA Netw Open, 2: e192597. 690. Kather JN, et al. (2019) Nat Med, 25: 1054. 691. Weiss J, et al. (2023) Nat Commun, 14: 2797. 692. Tran KA, et al. (2021) Genome Med, 13: 152. 693. Kong J, et al. (2022) Nat Commun, 13: 3703. 694. Michel A, et al. (2023) Breast Cancer Res Treat, 200: 237. 695. Kar A, et al. (2022) Biomaterials, 283: 121435. 696. Beg S, et al. (2022) Drug Discov Today, 27: 103314. 697. Mohamed MR, et al. (2023) Cancer, 129: 1096. 698. Partridge AH, et al. (2002) J Natl Cancer Inst, 94: 652. 699. Ma X, et al. (2023) Adv Sci (Weinh), 10: e2205343. 700. Du W, et al. (2023) Science Advances, 9: eadh5325. 701. Pew Research Center. About one-in-five Americans use a smart watch or fitness tracker. Accessed: July 5, 2023. Available from: https://www.pewresearch.org/shortreads/2020/01/09/about-one-in-five-americans-use-asmart-watch-or-fitness-tracker/. 702. Low CA (2020) NPJ Digit Med, 3: 140. 703. Teo NR, et al. (2023) Semin Oncol Nurs, 39: 151403. 704. Low CA, et al. (2018) Ann Behav Med, 52: 88. 705. Ohri N, et al. (2019) Int J Radiat Oncol Biol Phys, 105: 745. 706. Kos M, et al. (2023) Crit Rev Oncol Hematol, 185: 103979. 707. Torrente M, et al. (2022) Clin Med (Lond), 22: 36. 708. Thanarajasingam G, et al. (2023) medRxiv. 709. Shi DD, et al. (2022) Cancer Cell, 40: 939. 710. Pal S, et al. (2022) Cancer Cell, 40: 957. 711. Sonabend AM, et al. (2023) Lancet Oncol, 24: 509. 712. Enam SF, et al. (2022) Sci Adv, 8: eabq4882. 713. Yuan B, et al. (2022) Hum Vaccin Immunother, 18: 2055417. 714. Yu MW, et al. (2021) Front Immunol, 12: 676301. 715. Xiong Q, et al. (2023) Front Oncol, 13: 1192128. 716. Liau LM, et al. (2023) JAMA Oncol, 9: 112. 717. Mellenthin C, et al. (2022) Cancers (Basel), 14. 718. Owens DK, et al. (2019) JAMA, 322: 438. 719. Yang J, et al. (2021) Cancer Commun (Lond), 41: 1257. 720. ClinicalTrials.gov. A Study to Establish a New Onset Hyperglycemia and Diabetes Cohort (NOD). Accessed: July 5, 2023. Available from: https://www.clinicaltrials. gov/study/NCT03731637. 721. National Cancer Institute. Pancreatic Cancer Detection Consortium (PCDC). Accessed: July 5, 2023. Available from: https://prevention.cancer.gov/major-programs/ pancreatic-cancer-detection-consortium-pcdc. 722. Lee MS, et al. (2023) Nature, 616: 339. 723. Nwosu ZC, et al. (2023) Nature, 618: 151. 724. Chen Y, et al. (2022) Cancer Cell, 40: 818. 725. Freed-Pastor WA, et al. (2021) Cancer Cell, 39: 1342. 726. Roth MT, et al. (2020) F1000Res, 9. 727. Kemp SB, et al. (2023) Cancer Discov, 13: 298. 728. Strickler JH, et al. (2023) N Engl J Med, 388: 33. 729. Yeo D, et al. (2022) Mol Ther Oncolytics, 24: 561. 730. Kho ZY, et al. (2018) Front Microbiol, 9: 1835. 731. Doocey CM, et al. (2022) BMC Microbiol, 22: 53. 732. Purcell RV, et al. (2017) PLoS One, 12: e0171602. 733. Vijay-Kumar M, et al. (2010) Science, 328: 228. 734. Weersma RK, et al. (2020) Gut, 69: 1510. AACR Cancer Progress Report 2023 References 180
RkJQdWJsaXNoZXIy NTkzMzk=